A program to connect people with psoriasis through walking and talking

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the acceptability and feasibility of a 'Walk and Talk' intervention for adults with psoriasis, focusing on enhancing social connectedness and physical activity. Participants will be recruited from the Royal Free NHS Trust and must be able to walk for at least 30 minutes or be accompanied by a caregiver if using a wheelchair. The study will assess various outcome measures, including social connectedness, psychological wellbeing, and psoriasis severity, to inform future larger-scale studies. An 'opt-out' recruitment strategy will be employed to maximize participation and reduce bias.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18 years or over
* Diagnosed with psoriasis
* Currently attending psoriasis services in secondary care
* Must be able to walk for 30 minutes at a slow pace (approx 2km). Or be a wheelchair user with a carer who can push up hills if necessary

Exclusion Criteria:

* Participants who are not capable of understanding the information leaflet or consent form and thus are unable to give informed consent.
* Participants who do not understand verbal explanations or written information given in English will be excluded, as a number of questionnaires need to be completed. The translation service provided to the hospital is usually telephone operated.
* Participants not able to walk at a slow pace for 30 minutes will be excluded or wheelchair users who do not have a carer who can help to push up hills.
* Children will be excluded from study as this study involves making social interactions and contact with adults. This would not be appropriate, as child protection screens will not be performed on participants

Where it's running

• The Royal Free
  London, Greater London, United Kingdom Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HB0017 Injection safety and PK in low-weight adults at different injection sites

  This early-phase study tests a single subcutaneous HB0017 injection in healthy, low-weight adults and compares how the body processes the drug when injected at different sites.

  Recruiting Phase 1 Huabo Biopharm Co., Ltd. · Hangzhou, Zhejiang · NCT07920861

• Social Connection Collective for older adults in subsidized housing

  A resident-led program in subsidized housing in Baltimore will try to build friendships and peer support among residents aged 62 and older to see if it’s feasible and if it reduces loneliness.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07863583

• MK-8644: first-in-human test in healthy people and people with psoriasis

  This early-phase study tests MK-8644 versus placebo in healthy volunteers and people with psoriasis to see if it is safe and tolerable.

  Recruiting Phase 1 Merck Sharp & Dohme LLC · Melbourne, Victoria · NCT07850310

• Three-agent chat app for lonely older adults in Hong Kong

  This trial tests whether a Cantonese-language smartphone chat app with three conversational companions can help reduce loneliness in adults aged 60 and older in Hong Kong, by comparing a version powered by a large language model to a version using pre-written templates.

  Recruiting The University of Hong Kong · Hong Kong, Hong Kong SAR · NCT07822828

• Is XJH05 Ointment Effective for Plaque Psoriasis?

  This study tests whether the XJH05 ointment can help people with plaque psoriasis compare to a calcipotriol ointment.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07780929

• Guselkumab after Ustekinumab in adults with moderate-to-severe psoriasis in routine care

  This study looks at how well guselkumab works for people with moderate-to-severe psoriasis after switching from ustekinumab in everyday clinical practice.

  Recruiting Janssen-Cilag Kft. · Budapest · NCT07746583

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.